Pomona Ricerca is a private discovery-stage biotech company engaged in the design, development and production of proprietary fully human monoclonal antibodies with biological activities against human viral pathogensj like hepatitis C (HCV), influenza viruses, and multifocal leuko-encephalopathy (JC virus).

Pomona Ricerca, founded in 2010, brought together years of research work, acquiring the knowledge , the assets and the intellectual property of several small biotech companies, built upon the research of the two professors at San Raffaele University in the area of the prophylaxis and treatment of infectious diseases.

The inspiring scientists and originators of Pomona Ricerca, Professor Massimo Clementi (link), Professor of Microbiology and Virology and Dean of the School of Medicine of the Università Vita-Salute San Raffaele, and Professor Roberto Burioni (link), Associate of Microbiology and Virology at the same University, are among the key opinion leaders and internationally recognized experts in the field of human monoclonal antibodies and in the research of the host-pathogen interplay, with an outstanding publication track in this field.

Their work and consolidated know how in the specific sector puts also Pomona in a leading position for the design and the development of innovative epitope-based vaccines, able to elicit only the most active antibodies after administration to the patient.

From its incorporation, Pomona Ricerca has been financed by angel investors.

CEO and Legal Representative:  Massimo Ferrero
R&D: Gianni Garotta